You can help expand this article with text translated from the corresponding article in Russian. (June 2019) Click for important translation instructions.
|
Khimprom (Russian: Волгоградское открытое акционерное общество «Химпром», formerly known as Plant 91) was a major producer of industrial and consumer chemical products based in Volgograd, Russia.[1] The company used to manufacture organophosphorus nerve agents, and as of 2013 still produced dual-use chemicals.[2]
The plant was established in 1931.[3] The plant began production of sarin in 1959, and soman in 1967; production of both was officially ended before 1987. It was claimed that the plant manufactured 5 to 10 tons of binary nerve agent in 1991 as part of the Foliant research program, that was subsequently field tested at the Ust'yurt plateau, Uzbekistan.[4] In the post-Soviet era, the plant manufactured phosphorus oxychloride, and a range of phosphorus- and fluorine-containing compounds.[2]
The company's financial situation grew worse in the late 2000s, and it was officially declared bankrupt in 2012.[3] Production at the plant was fully discontinued in 2014.[5] In January 2015, layoffs began as the enterprise was being liquidated.[3] At the same time, projects were launched to restore the environmental damage caused by the plant during decades of chemical production.[3] As of May 2018, the local government is in talks with the Japan-based Marubeni to build a modern methanol plant on the Khimprom site.[3]
December 27, 2019 - liquidation of the organization.[6]
Bankruptcy trustee is Chertkova Inna Valeryevna (for 2024).[6]